Lezers Schrijven
 Crucell in de overgang. 31-05-2008
 Crucell, Start of Phase II Clinical Study for Rabie... 13-05-2008
 Crucell Announces First Quarter 2008 Results 13-05-2008
 Aeras, Crucell and SATVI Announce Encouraging Preli... 09-04-2008
 Crucell Announces First in Man Study with New Adeno... 03-04-2008
 Crucell Announces Start of Phase II Clinical Study ... 31-03-2008
 Crucell and DSM Biologics Announce Additional PER.C... 17-03-2008
 DSM and Crucell Announce PER.C6® Technology Milest... 11-03-2008
 Crucell Announces Fourth Quarter and Full Year 2007... 12-02-2008
 Crucell Reacts to Recent CEVEC Press Release 16-01-2008
 Crucell TRADING UPDATE 09-01-2008
 Crucell Enters Agreement with Sanofi Pasteur for Ne... 03-01-2008
 Aeras and Crucell Announce Start of a Tuberculosis ... 21-12-2007
 Crucell Announces Research License Agreement with P... 17-12-2007
 Crucell Presents Indian Phase I Rabies Antibody Coc... 30-11-2007
 Crucell Announces Third Quarter 2007 Results 13-11-2007
 Crucell Sells Stake in Pevion Biotech 12-11-2007
 Crucell Announces Marketing and Distribution Deal w... 12-11-2007
 Crucell presents Phase I results rabies antibody co... 03-10-2007
 Crucell discovers human monoclonal antibodies for..... 28-09-2007
 Crucell,Impact of discontinuation of Merck HIV stud... 25-09-2007
 Crucell to present pre-clinical results for H5N1 Vi... 14-09-2007
 Crucell announces new STAR® technology research li... 06-09-2007
 Crucell Announces Second Quarter 2007 Results 14-08-2007
 Crucell announces Vaccine and Protein Business Unit... 18-07-2007
 DSM Biologics and Crucell Announce PER.C6® Licensi... 10-07-2007
 Biotech zal ook een prooi kunnen gaan worden van KK... 03-06-2007
 Crucell, AERAS and SATVI Announce Start of Tubercul... 11-05-2007
 Crucell Announces First Quarter 2007 Results 09-05-2007
 Cruccell contra Innoconcepts. 07-04-2007
 Crucell broadens pandemic preparedness with grant a... 05-04-2007
 Crucell Announces Start of Rabies Phase I Antibody ... 04-04-2007
 Crucell secures important patent covering influenza... 03-04-2007
 Crucell announces European protein distribution dea... 03-04-2007
 Crucell Announces Large Scale Quinvaxem(TM) Vaccina... 23-03-2007
 Crucell announces influenza alliance with ADImmune ... 22-03-2007
 Aeras commits further USD$5 million to existing TB ... 07-03-2007
 Bericht Crucell 13-02-2007
 Crucell awarded EU grant to develop malaria vaccine 24-01-2007
 Crucell and DSM Biologics announce PER.C6® license... 11-01-2007
 Biotech is Booming 07-01-2007
 DSM Biologics and Crucell Announce PER.C6® Licensi... 05-01-2007
 Crucell, Merck & Co., Inc. and Crucell Sign Cross-l... 27-12-2006
 Crucell and NIH Gain Approval and Move to Recruitme... 19-12-2006
 Crucell Announces Start of Rabies Antibody Product ... 13-12-2006
 Crucell Awarded an additional Quinvaxem(TM) Vaccine... 08-12-2006
 Crucell Awarded Contracts of Over $230 Million for ... 01-12-2006
 Crucell Announces Acquisition of SBL Vaccin AB and ... 21-11-2006
 Crucell Announces Third Quarter 2006 Results 14-11-2006

Beperkte weergave !
Leden hebben toegang tot meer informatie! Omdat u nog geen lid bent of niet staat ingelogd, ziet u nu een beperktere pagina. Wordt daarom GRATIS Lid of login met uw wachtwoord

Copyrights © 2000 by XEA.nl all rights reserved
Niets mag zonder toestemming van de redactie worden gekopieerd, linken naar deze pagina is wel toegestaan.